Oscillators indicate a decent risk/reward entry now on ATHX (with tight stop). No chart reversal pattern apparent yet. High call interest and several pipeline catalysts set the stage early into next year. As a Plus ++ expect heighten interest in small tech bio regen medicine stocks as a new bio sector ETF during January kicks-off with PRMF's IPO. wrhambrecht.com/poliwogg-regenerative-medicine-fund/ I'd expect this IPO to have a positive affect on many of the regeneration medicine tickers.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.